Q3 results MPS Limited Reports Q3 Results and Announces Unbound Medicine Acquisition 4 weeks ago MPS Limited (NSE: MPSLTD) reported consolidated revenue of INR 18,249 lakh for the third quarter ended Dec. 31, 2025, a… Glenmark Pharmaceuticals Q3 FY26 Revenue Rises 15.1% on Strong Domestic and North American Growth 4 weeks ago Glenmark Pharmaceuticals Ltd. (NSE: GLENMARK) reported consolidated revenue of ₹39,006 million for the third quarter ended December 31, 2025, a…